Thromboangiitis Obliterans

Known as: TAO, obliterans thromboangiitis, buerger diseases 
An inflammatory vascular disorder that affects small and medium-sized arteries and veins in the extremities. The inflammatory process is initiated in… (More)

Topic mentions per year

Topic mentions per year

1936-2017
020406019362016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
BACKGROUND The short-term clinical benefits of bone marrow mononuclear cell transplantation have been shown in patients with… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2006
2006
BACKGROUND This study investigated the efficacy and safety of autologous bone marrow-mononuclear cells (ABMMNC) implantation in… (More)
Is this relevant?
2002
2002
Thromboangiitis obliterans (TAO) and antiphospholipid syndrome (APS) share the clinical characteristics of arterial thrombosis… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE Thromboangiitis obliterans (TAO), or Buerger's disease, a distinct form of vascular occlusive disease that afflicts the… (More)
Is this relevant?
1998
1998
The occurrence of autoimmune phenomena in 28 patients with thromboangiitis obliterans (Buerger's disease) was determined. The… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
A variety of chemicals, including triacetyloleandomycin (TAO), alpha-naphthoflavone (ANF), and diethyldithiocarbamate (DDC), are… (More)
Is this relevant?
1990
1990
Between 1970 and 1987, 112 patients were diagnosed as having thromboangiitis obliterans (TAO). The age was 42 +/- 11 years (mean… (More)
Is this relevant?
1987
1987
Thromboangiitis obliterans, a distinct clinical and pathologic entity characterized by segmental inflammatory and proliferative… (More)
Is this relevant?
1987
1987
Thromboangiitis obliterans (TAO), or Buerger's disease, is a distinct clinicopathologic entity. It is a relatively uncommon cause… (More)
Is this relevant?
1983
1983
We studied 39 patients with thromboangiitis obliterans to determine their cellular and humoral immune responses to native human… (More)
Is this relevant?